realstocky wrote: if u cant lose money, dont buy these stocks. LMNL is high beta, will go hard both ways...next is north. Dont come crying again.
AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019
PR Newswire - Thu Nov 28, 3:40PM CST
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 28, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ( " Liminal BioSciences " or the "Company " ), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, acknowledges the press release issued today by the Autorit des Marchs Financiers (" AMF ") in which the AMF announced that after a thorough investigation, the AMF has determined that no violation or breach of securities regulation occurred in connection with the refinancing transactions completed by the Company in April 2019 . The AMF is the regulatory and oversight body for Qubec's financial sector.
"We are pleased that the AMF has completed its review and concluded that it did not identify any violation or breach of securities regulation in the context of our refinancing transactions", stated Kenneth Galbraith , the Chief Executive Officer of Liminal BioSciences. "We have been cooperative and transparent with AMF throughout the review and look forward to focusing our efforts on developing and commercializing new medicines that may address serious unmet healthcare needs of patients around the world."
In April 2019 , the Company completed a series of refinancing transactions, which were subject to the prior review and approval of the Toronto Stock Exchange. On November 18 , 2019, the common shares of Liminal BioSciences commenced trading on the NASDAQ Global Market.